Y, Y., B, B., LJS, K., RJ, H., QL, C., J, A., . . . BD, T. (2026). A novel small molecule remyelination therapy for multiple sclerosis. Npj drug discovery, 3(1), . https://doi.org/10.1038/s44386-026-00060-7
Chicago Style (17th ed.) CitationY, Yang, Bai B, Knutsen LJS, Hamlyn RJ, Cui QL, Antel J, Macklin W, Medicetty S, and Trapp BD. "A Novel Small Molecule Remyelination Therapy for Multiple Sclerosis." Npj Drug Discovery 3, no. 1 (2026). https://doi.org/10.1038/s44386-026-00060-7.
MLA (9th ed.) CitationY, Yang, et al. "A Novel Small Molecule Remyelination Therapy for Multiple Sclerosis." Npj Drug Discovery, vol. 3, no. 1, 2026, https://doi.org/10.1038/s44386-026-00060-7.
Warning: These citations may not always be 100% accurate.